Mesothelioma Stages

What Are the Stages of Mesothelioma?

Mesothelioma has 4 stages. Staging tells your doctor how far the cancer has spread and helps guide treatment decisions. Median survival ranges from approximately 21 months at stage 1 to 12 months or less at stage 4.

The 4 Stages of Mesothelioma

• Stage 1: Cancer is localized to a single site and hasn’t spread. Tumors are small and removable via surgery. Median survival is about 21 months.
• Stage 2: Tumors can be seen in nearby tissues and possibly lymph nodes. Surgery is an option and chemotherapy can prevent spreading.
• Stage 3: Cancer has spread more into nearby organs and structures. Chemo and immunotherapy can shrink tumors.
• Stage 4: Tumors have spread to distant organs throughout the body. Tumor-removing surgery is no longer helpful, but systemic therapy can extend life.

The earlier your mesothelioma diagnosis, the more treatment options you’re likely to have. In stages 1 and 2, surgery and aggressive therapies are often possible. In stages 3 and 4, treatment focuses more on slowing the disease and managing symptoms to maintain quality of life.

Previous Next

Stage 1 Mesothelioma

Tumors are localized to the pleura and have not spread to lymph nodes or distant organs.

Stage 2 Mesothelioma

Tumors have grown and may involve nearby tissues or lymph nodes, but there is no distant metastasis.

Stage 3 Mesothelioma

Cancer has spread further into nearby structures and lymph nodes, which often limits surgical options.

Stage 4 Mesothelioma

Cancer has metastasized to distant organs, such as the liver, bones or brain, or is too widespread for tumor-removing surgery.

Stage 1 Mesothelioma

Stage 1 mesothelioma is the earliest stage when cancer is localized or still at the site where it first developed. It’s most likely located on the lining of the chest cavity, called the pleura, or the lining of the abdominal cavity, called the peritoneum. It hasn’t spread to lymph nodes or distant organs.

Symptoms are usually mild or nonexistent, which makes early detection difficult. A mesothelioma diagnosis at this stage often has the best prognosis.

Characteristics of Stage 1 Mesothelioma

• Cancer is localized to its original site
• Symptoms are mild or nonexistent
• Treatment options: surgery, chemo and radiation

Pleural mesothelioma survivor Daniel McCarthy was diagnosed at an earlier stage, making surgery an option for him. He tells us, “My wife is a nurse and noticed I was short of breath. She convinced me to see a doctor, and it basically saved my life.” 

With early detection, aggressive treatments such as surgery and multimodal therapy offer the best chance of long-term survival. Seeking care from a mesothelioma specialist can help ensure you explore all available options.

Stage 2 Mesothelioma

At stage 2, mesothelioma has started to spread beyond its origin into nearby lung, diaphragm, cardiac or abdominal tissue. Symptoms such as mild chest pain, coughing, nausea, abdominal discomfort and shortness of breath may begin to appear. 

Early-stage treatment remains aggressive, and multiple options are available. Multimodal therapy, which combines treatments like surgery, chemo and radiation, is often recommended. Clinical trials may offer additional opportunities.

Characteristics of Stage 2 Pleural Mesothelioma

• Cancer has spread into nearby tissue
• Symptoms such as cough or pain may be vague
• Treatment options: surgery, chemo and radiation

Diagnosed with stage 2 pleural mesothelioma in 2020, survivor Cheryl Pilkington tells us her doctors were surprised. But she says she and her sister often played in plaster dust in her father’s foundry shop. They were unaware the dust also contained asbestos.

“They never suspected [pleural mesothelioma],” Cheryl shares. “A female who was not in any business where there was asbestos exposure. They were shocked when the biopsy came back, but only until they heard my history.”

FREE MESOTHELIOMA TREATMENT GUIDE

Expert Guidance for Your Mesothelioma Journey

Get answers about treatment, top doctors, and clinical trials from the nation’s most trusted mesothelioma resource.

Get Your Free Guide

Stage 3 Mesothelioma

Stage 3 mesothelioma means the cancer has spread further into nearby structures such as the chest or abdominal wall, esophagus or deeper into the diaphragm and abdominal organs. Symptoms become more noticeable, including persistent chest pain, vomiting, difficulty breathing and fatigue.

Characteristics of Stage 3 Mesothelioma

• Cancer has spread to nearby organs and lymph nodes
• Symptoms include chest or belly pain, fatigue and breathing difficulties
• Treatment options: chemo, immunotherapy and palliative care

Often surgery isn’t an option at this stage. But chemo, immunotherapy and palliative treatments can help manage symptoms and slow disease progression. Some people may qualify for clinical trials testing new therapies.

Pleural mesothelioma survivor Russell Lamkins tells us, “When I was first diagnosed with stage 3 inoperable cancer, I was told I had a year to live. I figured I’d better hurry up and finish the projects I was working on. But now, my goal is to make it to the 10-year mark.”

Stage 4 Mesothelioma

Stage 4 is the most advanced stage of mesothelioma. Cancer has spread to distant organs such as the liver, brain or bones. Symptoms are severe and may include significant weight loss, extreme fatigue and breathing difficulties.

Characteristics of Stage 4 Mesothelioma

• Cancer has spread to multiple sites or distant organs
• Symptoms include severe fatigue, weight loss and respiratory issues
• Treatment options: palliative care, immunotherapy and clinical trials

Treatment often focuses on palliative care, pain management and oxygen therapy. Some patients explore immunotherapy or clinical trials to extend survival. Nearly 53% of mesothelioma health care professionals we surveyed told us they recommend immunotherapy as a first-line treatment for patients with inoperable malignant mesothelioma.

Comparing the 4 Stages of Mesothelioma

The 4 stages of mesothelioma differ in how far the cancer has spread, what symptoms you may experience and which treatments are available. Earlier stages generally offer more treatment options, better outcomes and longer median survival, while later stages usually focus on managing symptoms and maintaining quality of life.

Mesothelioma Symptoms By Stage

Mesothelioma symptoms are generally mild and easier to overlook in the early stages. In stages I and II, most people experience no symptoms or only nonspecific concerns, such as fatigue, chest pressure or abdominal discomfort. 

As tumors develop in stages III and IV, more fluids accumulate, shortness of breath with exercise increases and chest pain worsens. Abdominal swelling, nausea or changes in bowel habits are also more apparent.

Early vs. Late Stage Mesothelioma Symptoms

Mesothelioma symptoms vary significantly by stage. Early-stage patients often experience few or no symptoms, while late-stage patients typically face severe respiratory distress, pain and a significant decline in overall health.

In early stages, symptoms may be mild or come and go. If you’ve been around asbestos and notice any changes to your health, consult a mesothelioma specialist. At stages 3 and 4, your care team can help manage severe symptoms through palliative procedures and medications to improve breathing, reduce fluid buildup and maintain comfort.

How Is My Mesothelioma Stage Determined?

Mesothelioma staging requires a combination of imaging tests, tissue biopsy and sometimes surgical exploration to determine the exact extent of cancer spread. Imaging scans also play a key role.

Staging is typically approached in two ways. Clinical staging uses imaging and biopsy results to estimate cancer extent before treatment. Pathological staging happens during or after surgery and provides a more precise assessment.

Stage Diagnostic Tests

• Biopsy: Doctors remove a small tissue sample through a needle or a camera-assisted thoracoscopy (chest) or laparoscopy (abdomen) to confirm your mesothelioma cell type, stage and treatment options.
• CT scan: A computed tomography scan of the chest, abdomen or pelvis indicates your stage based on tumor size, location, fluid accumulation and potential invasion into surrounding tissue or lymph nodes. 
• Fluid cytology: Doctors test pleural or peritoneal fluid from drainage to suggest mesothelioma, but it doesn’t definitively stage it without biopsy of the tissue. It can help guide your treatment.
• Lymph node evaluation: A lymph node evaluation through mediastinoscopy or endobronchial ultrasound, also known as EBUS, is a guided needle biopsy obtained from your airways.
• MRI: This imaging scan provides a detailed picture of your chest wall, diaphragm or intra-abdominal organs, helping your surgeon determine tissue involvement, which could change the stage or surgical approach.
• PET-CT: Positron emission tomography, or PET, adds fluorescence to a CT scan to highlight areas with active cancer cells and identify disease in areas such as lymph nodes that are harder to see.
• Thoracoscopy/laparoscopy: Thoracoscopy (in the chest) or laparoscopy (in the abdomen) lets your surgeon see directly into either cavity, remove or drain excess fluid and obtain biopsies.

Doctors assess the information from these tests using specific systems for your type of mesothelioma. The TNM system is the most widely used for pleural mesothelioma. For peritoneal mesothelioma, doctors use the Peritoneal Cancer Index, a scoring system that estimates how much tumor is present and where it’s located throughout the abdomen.

500+ SPECIALISTS AVAILABLE

Get to the Right Doctor, Faster

Connect with top-rated doctors specializing in mesothelioma treatment, who will personalize treatment options based on your diagnosis.

Find Your Doctor

Emerging Approaches to Mesothelioma Staging

While TNM staging remains the standard for mesothelioma, emerging tools such as liquid biopsy, AI-assisted imaging and molecular profiling may complement traditional staging methods in the future. These approaches aim to detect cancer earlier, track treatment response more precisely and refine prognosis beyond anatomical staging alone.

Emerging Staging Tools to Watch

• AI-assisted imaging: Machine learning algorithms applied to CT and PET-CT scans may improve staging accuracy by identifying subtle tumor spread patterns that are harder to detect visually.
• Biomarker-based staging: Blood proteins such as mesothelin, fibulin-3 and osteopontin are being studied as potential staging indicators, along with an inflammatory signature score that may predict how tumors respond to treatment.
• Liquid biopsy: Blood-based tests that detect circulating tumor DNA and tumor cells may enable less invasive staging and help doctors monitor how the disease changes over time.
• Molecular profiling: Genomic analysis of tumor DNA, including BAP1 mutations and CDKN2A deletions, may refine prognosis beyond what anatomical staging alone can show.

Research also shows that early-stage mesothelioma diagnoses are slowly increasing. Data from 2025 found that the proportion of early-stage cases rose from 13.5% to 15.6% between 2010 and 2020, and the share of people who received treatment climbed from 71% to 76% over the same period. You can learn more about mesothelioma blood tests and emerging treatments to see how these tools may fit into your care.

Staging System for Pleural Mesothelioma

The TNM staging system is the only official staging system for pleural mesothelioma. Mesothelioma stages directly impact prognosis. According to the Canadian Cancer Society, life expectancy ranges from 21 to 51 months after a stage 1 diagnosis to 8 to 12 months when diagnosed with stage 4 mesothelioma.

• Tumor (T): Measures the size and location of the primary tumor, ranging from T0 (no tumor) to T4 (advanced tumor that has spread beyond the pleura).
• Node (N): Determines whether cancer has spread to lymph nodes, ranging from N0 (no lymph node involvement) to N3 (cancer has spread to lymph nodes on the opposite side of the chest).
• Metastasis (M): Identifies whether cancer has traveled to distant organs. M0 means no distant spread is present, while M1 means it is.

Before TNM became the standard, doctors used the Butchart and Brigham staging systems. TNM replaced them because it provides more detailed, consistent criteria that can be applied across medical centers worldwide.

What TNM Staging Changes Could Mean for You

The TNM system was updated in January 2025 with the introduction of the 9th edition, which refined how doctors measure and describe tumor spread. If you were diagnosed before 2025, your staging likely used the 8th edition.

The core T, N and M framework remains the same, but some specific criteria changed in ways that can shift your overall stage. For example, the 9th edition now considers whether tumors have grown along the fissures between lung lobes, which can mean being diagnosed in a more advanced stage.

Questions to Ask Your Doctor

• Which TNM edition was used to stage my cancer?
• Could the 9th edition criteria change my stage?
• Do these staging changes affect my treatment plan?
• Should I consider a restaging evaluation under the updated criteria?

Most patients won’t notice a significant difference in their staging. If you were diagnosed around the time of the January 2025 transition, it’s worth asking your care team which edition they used.

Do All Types of Mesothelioma Have Staging Systems?

Doctors use a formal TNM staging system for pleural mesothelioma. They rely on different methods for other types. Peritoneal, pericardial and testicular mesothelioma each use their own approach to describe how far tumors spread and to guide treatment planning.

Insight From a Mesothelioma Specialist

If a doctor refers to peritoneal mesothelioma as stage 3, it usually means tumors have spread throughout the abdominal lining and to nearby lymph nodes.

Dr. Daniel Landau, oncologist and medical director of Virtual Hematology at the Medical University of South Carolina

Peritoneal Mesothelioma and the PCI

Doctors don’t use the TNM system for peritoneal mesothelioma. Instead they use the Peritoneal Cancer Index, or PCI, a scoring system that divides the abdomen into 13 regions and scores the largest tumor in each area from 0 to 3. 

Doctors add all 13 scores to calculate a total from 0 to 39, with higher scores reflecting more widespread disease. Surgeons and oncologists use the PCI to decide whether a person can safely undergo cytoreductive surgery with HIPEC. Doctors also use a completeness of cytoreduction score, or CC score, with the PCI to show how much visible tumor remains after surgery. 

Researchers are also exploring a newly proposed peritoneal mesothelioma staging system that factors in tumor behavior, including how quickly cells divide and cell type, to more precisely predict outcomes. This work is still being validated across multiple centers.

Pericardial Mesothelioma

Pericardial mesothelioma accounts for only 1 to 2% of all mesothelioma cases and is often diagnosed at an advanced stage or at autopsy, which limits the value of a formal staging system. Rather than a dedicated system, doctors adapt general cardiac or thoracic cancer staging frameworks, focusing on whether tumors are confined to the pericardium, have grown into nearby heart structures or have spread to distant sites.

Testicular Mesothelioma

Testicular mesothelioma is the rarest type but often carries the best prognosis, with approximately 50% of patients surviving 5 years or longer. Doctors sometimes stage it using a modified TNM system that includes an extra “S” category for serum tumor marker levels, similar to the approach used for testicular germ cell tumors. Staging considers whether tumors are confined to the tunica vaginalis, involve nearby lymph nodes or have spread to distant organs, with the S marker level used to refine prognosis and guide follow-up.

Expert Insights

Dr. Jacques Fontaine: Early-Stage vs Late-Stage Mesothelioma Treatment Options

View Transcript

The earlier a patient gets diagnosed with mesothelioma, when the tumor has not gone to lymph nodes or has not gone to other organs, the more the patient has options in terms of treatment and the better the prognosis.

Unfortunately, mesothelioma sometimes is a difficult diagnosis to make and patients get diagnosed when the cancer is at a later stage, stage three or stage four mesothelioma.

In those circumstances, treatment options are fewer, still exist, and we still have hope. But of course, the treatment options sometimes are fewer than if it was early stage. Specifically when it comes to surgery. Surgery can sometimes in selected patients help an early stage mesothelioma. Then later stage mesothelioma surgery should be geared towards palliating symptoms, making patients more comfortable, allowing patients to have a better quality of life rather than trying to get all the disease out. The goal of the surgery in stage three or stage four mesothelioma is to improve their quality of life.

How Does My Mesothelioma Stage Affect My Treatment Options & Prognosis?

As mesothelioma progresses or moves from earlier stages to later stages, it can affect what treatment options are most likely to offer someone the best outcome. Typically, surgery and other aggressive therapies may be possible in stages 1 and 2. For stages 3 and 4, treatment often focuses more on slowing the disease and managing mesothelioma symptoms. Along with stage, cell type (epithelioid, sarcomatoid or biphasic) strongly influences prognosis and how well treatments may work.

The Role of Staging in Treatment Plans

• Stages 1-2: Surgery, chemo and radiation therapy are often treatment options.
• Stage 3: Treatment focuses on slowing tumor growth using chemo and immunotherapy.
• Stage 4: Care centers on improving quality of life through symptom and pain management, along with oxygen therapy.

Dr. Fontaine emphasizes the importance of personalized care. He tells us, “The mesothelioma patients I treat who are good candidates for surgery are usually in the early stages, when the cancer is confined to the lung lining, hasn’t reached the lymph nodes and hasn’t spread to other organs.”

For pleural mesothelioma, 5-year survival rates range from 7% to 24%, depending on the stage at diagnosis, according to the American Cancer Society. But mesothelioma survival rate data is based on cases diagnosed years ago and can’t predict individual outcomes. While the typical mesothelioma life expectancy ranges from 22.2 months at stage 1 to 14.9 months at stage 4, new and advanced therapies are extending survival.

Asbestos.com Expert Takeaway

Expert Takeaways on Mesothelioma Staging

• Staging mesothelioma requires CT scans PET scans, according to a review published in the Journal of Clinical Medicine.
• Assessing the correct stage informs doctors about a mesothelioma patient’s prognosis and life expectancy.

“This is crucial because you need to know the extent of the disease in your body in order to get the most ideal tailored treatment regimen; thus, all patients should have, at a minimum, a CT scan and PET scan to start with.”

Dr. Jeffrey Velotta, thoracic surgeon at Kaiser Permanente Oakland Medical Center

Common Questions About Mesothelioma Stages

At what stage is mesothelioma diagnosed?

Mesothelioma can be diagnosed at any stage, from I through IV. About 75% to 80% of people receive a diagnosis at stage 3 or 4 because early-stage tumors often don’t cause clear symptoms. A 2025 analysis of U.S. data found that the share of early-stage diagnoses slowly increased from 13.5% to 15.6% between 2010 and 2020, and the share of people who received treatment rose from 71% to 76%. These trends suggest that earlier detection and better access to care may help more people enter treatment while the disease is still limited in spread.

How fast does mesothelioma progress?

Mesothelioma progression varies widely from person to person. Some people stay stable for many months, while others notice changes within weeks. The rate of growth depends on factors such as cell type, age, overall health and how the cancer affects key organs. Epithelioid mesothelioma usually grows more slowly than other types, while sarcomatoid mesothelioma often progresses faster and may be harder to control. Biphasic tumors, which mix cell types, follow an intermediate pattern.

Is stage 4 mesothelioma always terminal?

Mesothelioma has no cure and is considered a terminal cancer, but treatment can still extend life and improve comfort. Stage 4 means the cancer has spread widely, which limits surgical options and makes long-term remission less likely. However, some people with stage 4 mesothelioma have lived beyond average life expectancy through newer therapies such as immunotherapy, including the nivolumab and ipilimumab combination approved for unresectable mesothelioma. Some patients mesothelioma remission or outlive their prognosis through newer therapies, clinical trials and combination treatments.

Should I get a second opinion about my stage or diagnosis?

Yes. Getting a mesothelioma second opinion can confirm your stage and sometimes change your treatment plan. Staging accuracy depends on the imaging methods used, the pathologist’s experience and the center’s familiarity with rare cancers like mesothelioma. High-volume mesothelioma centers often have more up-to-date staging practices and access to advanced therapies. A second opinion can also open additional options such as surgery, multimodal therapy or clinical trials.

Can mesothelioma be restaged after treatment?

Yes. Doctors can restage mesothelioma after surgery, chemotherapy or other mesothelioma treatment if they need to reassess how much cancer remains. Restaging usually involves new imaging tests such as CT or PET-CT scans and sometimes repeat biopsies. The result can show whether treatment shrank the tumor, stabilized the disease or allowed the cancer to grow, and may change which therapies doctors recommend next.

What does unresectable mesothelioma mean?

Unresectable mesothelioma means surgeons can’t safely remove all visible cancer. The tumor may wrap around vital organs, spread too far through the chest or abdomen or lie in areas that surgery can’t reach without excessive risk. Most stage 4 cases and some advanced stage 3 tumors fall into this category. When mesothelioma is unresectable, doctors usually focus on chemotherapy, immunotherapy and palliative options to control growth and ease symptoms.

What is the difference between the 8th and 9th edition TNM staging for mesothelioma?

The 8th edition, which was standard before January 2025, used certain tumor descriptors that CT imaging cannot always accurately detect. The 9th edition, which the International Association for the Study of Lung Cancer proposed, removed those descriptors and introduced fissure involvement and pleural thickness measurements as new ways to assess tumor spread. The lymph node and metastasis categories remain unchanged in both editions. If you were diagnosed around the time of the January 2025 transition, it’s worth asking your care team which edition was used.